Creative Planning Takes $725,000 Position in GRAIL, Inc. $GRAL

Creative Planning purchased a new stake in GRAIL, Inc. (NASDAQ:GRAL) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 14,093 shares of the company’s stock, valued at approximately $725,000.

Several other large investors have also recently bought and sold shares of GRAL. Police & Firemen s Retirement System of New Jersey boosted its position in GRAIL by 69.7% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 6,919 shares of the company’s stock valued at $356,000 after buying an additional 2,841 shares during the last quarter. Geode Capital Management LLC boosted its holdings in GRAIL by 60.4% in the second quarter. Geode Capital Management LLC now owns 757,770 shares of the company’s stock valued at $38,969,000 after acquiring an additional 285,331 shares during the last quarter. PNC Financial Services Group Inc. boosted its holdings in GRAIL by 38.9% in the second quarter. PNC Financial Services Group Inc. now owns 8,450 shares of the company’s stock valued at $434,000 after acquiring an additional 2,365 shares during the last quarter. Nwam LLC increased its position in GRAIL by 93.0% in the second quarter. Nwam LLC now owns 20,613 shares of the company’s stock worth $1,060,000 after purchasing an additional 9,932 shares during the period. Finally, ProShare Advisors LLC bought a new stake in GRAIL during the 2nd quarter worth about $391,000.

GRAIL Stock Performance

Shares of NASDAQ:GRAL opened at $97.38 on Wednesday. The company has a 50 day moving average price of $80.92 and a two-hundred day moving average price of $53.64. The company has a market capitalization of $3.80 billion, a PE ratio of -8.37 and a beta of 4.23. GRAIL, Inc. has a 52 week low of $16.10 and a 52 week high of $115.76.

GRAIL (NASDAQ:GRAL) last announced its quarterly earnings results on Wednesday, November 12th. The company reported ($2.46) earnings per share (EPS) for the quarter, beating the consensus estimate of ($3.40) by $0.94. GRAIL had a negative net margin of 286.43% and a negative return on equity of 15.69%. The company had revenue of $36.19 million during the quarter, compared to analyst estimates of $33.83 million. On average, sell-side analysts forecast that GRAIL, Inc. will post -15.15 earnings per share for the current year.

Insider Transactions at GRAIL

In other GRAIL news, President Joshua J. Ofman sold 81,385 shares of the stock in a transaction dated Monday, October 6th. The stock was sold at an average price of $62.50, for a total value of $5,086,562.50. Following the completion of the sale, the president directly owned 396,797 shares in the company, valued at $24,799,812.50. This represents a 17.02% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Robert P. Ragusa sold 7,239 shares of GRAIL stock in a transaction dated Wednesday, October 15th. The shares were sold at an average price of $68.88, for a total value of $498,622.32. Following the transaction, the chief executive officer owned 727,388 shares in the company, valued at $50,102,485.44. This trade represents a 0.99% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 113,295 shares of company stock valued at $7,380,888.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on GRAL. Guggenheim raised shares of GRAIL from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a research note on Wednesday, November 12th. Weiss Ratings restated a “sell (d-)” rating on shares of GRAIL in a report on Wednesday, October 8th. Morgan Stanley lifted their target price on shares of GRAIL from $85.00 to $110.00 and gave the stock an “equal weight” rating in a report on Monday. Canaccord Genuity Group upped their target price on shares of GRAIL from $85.00 to $105.00 and gave the company a “buy” rating in a research report on Monday, November 17th. Finally, UBS Group set a $75.00 price target on GRAIL in a research report on Friday, October 3rd. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $97.50.

GRAIL Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.